Effect of nabiximols oromucosal spray (Sativex®) on symptoms associated with multiple sclerosis-related spasticity: a case series
Spasticity and its related symptoms of spasms, pain, sleep disturbance and bladder dysfunction are common in persons with multiple sclerosis (MS) and may be interconnected through a common pathophysiology and/or may trigger and worsen each other. Tetrahydrocannabinol–cannabidiol (nabiximols) oromuco...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BioExcel Publishing Ltd
2024-02-01
|
| Rangatū: | Drugs in Context |
| Ngā marau: | |
| Urunga tuihono: | https://www.drugsincontext.com/effect-of-nabiximols-oromucosal-spray-sativex-on-symptoms-associated-with-multiple-sclerosis-related-spasticity-a-case-series/ |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|